Skip to content


Critical Care

Open Access

Back to basics in sepsis treatment: critically ill patients need intensive care

  • Jack JM Ligtenberg1Email author,
  • Jaan C ter Maaten1 and
  • Jan G Zijlstra2
Critical Care201418:405

Published: 31 January 2014

Marik and Bellomo reason that stress hyperglycemia might be an essential survival response [1]. We reviewed the same question in this journal, before multi-center studies on glycemic control were published [2]. It strikes us that of almost all novel therapies in septic patients, few appear to withstand time. If everything has been futile, did we cause iatrogenic damage, as suggested [1], and is there reason to become cynical? We think the original studies gave rise to good developments. First, the Rivers protocol led to the implementation of limited sepsis treatment bundles resulting in a mortality decrease. Second, the results and the glycemic control of studies by Greet van den Berghe appeared to be not that simple to achieve in real life. Third, lactate-guided therapy improved outcomes, although without an exactly known mechanism [3]. Fourth, a subset analysis of the Surviving Sepsis Campaign database including nearly 9,000 patients revealed that low-dose steroid treatment is associated with an increase in hospital mortality [4]. Fifth, look at all the hemodynamic optimization trials… Notwithstanding the disappointing results of follow-up studies, the original studies were important because they increased recognition of septic patients, led to more original ideas [5], and to effective treatment bundles not funded by third parties [6]. An important common denominator is the intensive attention that all these studies required for their execution, increasing the recognition of septic patients and re-evaluating treatment in a timely manner. These initial studies should make us humble and proud at the same time.

Authors’ response

Paul E Marik and Rinaldo Bellomo

We thank Dr Ligtenberg and colleagues for their comments regarding our paper on stress hyperglycemia [1]. We would argue that tight glycemic control may have led to patients receiving therapy that was harmful (too much insulin) [7], that the Rivers protocol has not been validated and may have led to harm (too much fluid, too much blood) [8, 9] and that lactate-guided therapy is a misnomer as an oxygen debt is unlikely in sepsis and this approach will lead to excessive interventions (too much fluid, inotropic agents and blood) [10, 11]. The steroid effect reported from the Surviving Sepsis Campaign database may just represent selection bias [4]. We advocate a healthy dose of skepticism rather than cynicism. Furthermore, when it comes to the critically ill, 'less may be more’ [12].


Authors’ Affiliations

Emergency Department, University Medical Center Groningen (UMCG), Groningen, Netherlands
Critical Care Department, University Medical Center Groningen (UMCG), Groningen, Netherlands


  1. Marik PE, Bellomo R: Stress hyperglycemia: an essential survival response! Crit Care 2013, 17: 305. 10.1186/cc12514PubMed CentralView ArticlePubMedGoogle Scholar
  2. Corstjens AM, van der Horst ICC, Zijlstra JG, Groeneveld ABJ, Tulleken JE, Zijlstra F, Ligtenberg JJM: Hyperglycemia in critically ill patients - marker or mediator of mortality. Crit Care 2006, 10: 216. 10.1186/cc4957PubMed CentralView ArticlePubMedGoogle Scholar
  3. de Ruiter J, Zijlstra JG, Ligtenberg JJM: Does lactate-guided therapy really improve outcome? Am J Respir Crit Care Med 2011, 183: 680-681.View ArticlePubMedGoogle Scholar
  4. Casserly B, Gerlach H, Phillips GS, Lemeshow S, Marshall JC, Osborn TM, Levy MM: Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign. Intensive Care Med 2012, 38: 1946-1954. 10.1007/s00134-012-2720-zView ArticlePubMedGoogle Scholar
  5. Marik PE, Bellomo R: Re-thinking resuscitation goals: an alternative point of view. Crit Care 2013, 17: 458. 10.1186/cc12775PubMed CentralView ArticlePubMedGoogle Scholar
  6. Zijlstra JG, Monteban WE, Tulleken JE, Meertens JHJM, Ligtenberg JJM: Septic shock therapy: the recipe or the cook? Crit Care Med 2006, 34: 2870.View ArticlePubMedGoogle Scholar
  7. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hébert PC, Heyland DK, Robinson BG, NICE-SUGAR Study Investigators: Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367: 1108-1118.View ArticlePubMedGoogle Scholar
  8. Marik PE: Surviving sepsis: going beyond the guidelines. Ann Intensive Care 2011, 1: 17. 10.1186/2110-5820-1-17PubMed CentralView ArticlePubMedGoogle Scholar
  9. Fuller BM, Gajera M, Schorr C, Gerber D, Dellinger RP, Parrillo J, Zanotti S: The impact of packed red blood cell transfusion on clinical outcomes in patients with septic shock treated with early goal directed therapy. Indian J Crit Care Med 2010, 14: 165-169. 10.4103/0972-5229.76078PubMed CentralView ArticlePubMedGoogle Scholar
  10. Marik PE, Bellomo R: Lactate clearance as a target of therapy in sepsis: a flawed paradigm. OA Crit Care 2013, 1: 3.View ArticleGoogle Scholar
  11. Garcia-Alvarez M, Marik PE, Bellomo R: Stress hyperlactemia. Lancet Endo Diabetes 2014. in pressGoogle Scholar
  12. Knox M, Pickkers P: “Less is more” in critically ill patients. Not too intensive. JAMA Intern Med 2013, 173: 1369-1372. 10.1001/jamainternmed.2013.6702View ArticleGoogle Scholar


© BioMed Central Ltd. 2014